A combination of techniques including, chromatin immunoprecipitation (ChIP)-sequencing, RNA-sequencing and microarray-based gene expression profiling, plus rapid immunoprecipitation mass spectrometry, were employed to provide insights into the possible role of nuclear PAI-1 and its impact on cancer cell gene expression profiles. This evidence concerns the gene SERPINE1 and cancer.